Identification of distinct cytotoxic granules as the origin of supramolecular attack particles in T lymphocytes.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
24 02 2022
Historique:
received: 04 05 2021
accepted: 24 01 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 13 4 2022
Statut: epublish

Résumé

Cytotoxic T lymphocytes (CTL) kill malignant and infected cells through the directed release of cytotoxic proteins into the immunological synapse (IS). The cytotoxic protein granzyme B (GzmB) is released in its soluble form or in supramolecular attack particles (SMAP). We utilize synaptobrevin2-mRFP knock-in mice to isolate fusogenic cytotoxic granules in an unbiased manner and visualize them alone or in degranulating CTLs. We identified two classes of fusion-competent granules, single core granules (SCG) and multi core granules (MCG), with different diameter, morphology and protein composition. Functional analyses demonstrate that both classes of granules fuse with the plasma membrane at the IS. SCG fusion releases soluble GzmB. MCGs can be labelled with the SMAP marker thrombospondin-1 and their fusion releases intact SMAPs. We propose that CTLs use SCG fusion to fill the synaptic cleft with active cytotoxic proteins instantly and parallel MCG fusion to deliver latent SMAPs for delayed killing of refractory targets.

Identifiants

pubmed: 35210420
doi: 10.1038/s41467-022-28596-y
pii: 10.1038/s41467-022-28596-y
pmc: PMC8873490
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1029

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Dustin, M. L. & Long, E. O. Cytotoxic immunological synapses. Immunol. Rev. 235, 24–34 (2010).
pubmed: 20536553 pmcid: 2950621 doi: 10.1111/j.0105-2896.2010.00904.x
Golstein, P. & Griffiths, G. M. An early history of T cell-mediated cytotoxicity. Nat. Rev. Immunol. 18, 527–535 (2018).
pubmed: 29662120 doi: 10.1038/s41577-018-0009-3
Voskoboinik, I., Whisstock, J. C. & Trapani, J. A. Perforin and granzymes: function, dysfunction and human pathology. Nat. Rev. Immunol. 15, 388–400 (2015).
pubmed: 25998963 doi: 10.1038/nri3839
Bossi, G. & Griffiths, G. M. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat. Med. 5, 90–96 (1999).
pubmed: 9883845 doi: 10.1038/4779
Bossi, G., Stinchcombe, J. C., Page, L. J. & Griffiths, G. M. Sorting out the multiple roles of Fas ligand. Eur. J. Cell Biol. 79, 539–543 (2000).
pubmed: 11001490 doi: 10.1078/0171-9335-00077
Hong, W. Cytotoxic T lymphocyte exocytosis: bring on the SNAREs! Trends Cell Biol. 15, 644–650 (2005).
pubmed: 16260137 doi: 10.1016/j.tcb.2005.10.003
Stow, J. L., Manderson, A. P. & Murray, R. Z. SNAREing immunity: the role of SNAREs in the immune system. Nat. Rev. Immunol. 6, 919–929 (2006).
pubmed: 17124513 doi: 10.1038/nri1980
Matti, U. et al. Synaptobrevin2 is the v-SNARE required for cytotoxic T-lymphocyte lytic granule fusion. Nat. Commun. 4, 1439 (2013).
pubmed: 23385584 doi: 10.1038/ncomms2467
Chitirala, P. et al. Cytotoxic granule exocytosis from human cytotoxic T lymphocytes is mediated by VAMP7. Front. Immunol. 10, 1855 (2019).
pubmed: 31447853 pmcid: 6692471 doi: 10.3389/fimmu.2019.01855
Marks, M. S., Heijnen, H. F. & Raposo, G. Lysosome-related organelles: unusual compartments become mainstream. Curr. Opin. Cell Biol. 25, 495–505 (2013).
pubmed: 23726022 pmcid: 3729921 doi: 10.1016/j.ceb.2013.04.008
Peters, P. J. et al. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J. Exp. Med. 173, 1099–1109 (1991).
pubmed: 2022921 doi: 10.1084/jem.173.5.1099
Raja, S. M. et al. Cytotoxic cell granule-mediated apoptosis. Characterization of the macromolecular complex of granzyme B with serglycin. J. Biol. Chem. 277, 49523–49530 (2002).
pubmed: 12388539 doi: 10.1074/jbc.M209607200
Metkar, S. S. et al. Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. Immunity 16, 417–428 (2002).
pubmed: 11911826 doi: 10.1016/S1074-7613(02)00286-8
Grujic, M. et al. Serglycin-deficient cytotoxic T lymphocytes display defective secretory granule maturation and granzyme B storage. J. Biol. Chem. 280, 33411–33418 (2005).
pubmed: 16046402 doi: 10.1074/jbc.M501708200
Sutton, V. R. et al. Serglycin determines secretory granule repertoire and regulates natural killer cell and cytotoxic T lymphocyte cytotoxicity. FEBS J. 283, 947–961 (2016).
pubmed: 26756195 doi: 10.1111/febs.13649
Grujic, M. et al. Delayed contraction of the CD8+ T cell response toward lymphocytic choriomeningitis virus infection in mice lacking serglycin. J. Immunol. 181, 1043–1051 (2008).
pubmed: 18606656 doi: 10.4049/jimmunol.181.2.1043
Clark, R. & Griffiths, G. M. Lytic granules, secretory lysosomes and disease. Curr. Opin. Immunol. 15, 516–521 (2003).
pubmed: 14499259 doi: 10.1016/S0952-7915(03)00113-4
Griffiths, G. M. & Argon, Y. Structure and biogenesis of lytic granules. Curr. Top. Microbiol. Immunol. 198, 39–58 (1995).
pubmed: 7774282
Page, L. J., Darmon, A. J., Uellner, R. & Griffiths, G. M. L is for lytic granules: lysosomes that kill. Biochim. Biophys. Acta 1401, 146–156 (1998).
pubmed: 9531970 doi: 10.1016/S0167-4889(97)00138-9
Peters, P. J. et al. Molecules relevant for T cell-target cell interaction are present in cytolytic granules of human T lymphocytes. Eur. J. Immunol. 19, 1469–1475 (1989).
pubmed: 2789142 doi: 10.1002/eji.1830190819
Podack, E. R. & Konigsberg, P. J. Cytolytic T cell granules. Isolation, structural, biochemical, and functional characterization. J. Exp. Med. 160, 695–710 (1984).
pubmed: 6332169 doi: 10.1084/jem.160.3.695
Balint, S. et al. Supramolecular attack particles are autonomous killing entities released from cytotoxic T cells. Science 368, 897–901 (2020).
pubmed: 32381591 pmcid: 7116847 doi: 10.1126/science.aay9207
Murphy, K. & Weaver, C. Cytotoxic effector proteins that trigger apoptosis are contained in the granules of CD8 cytotoxic T cells. In: Janeway’s Immunobiology 9th Edition). 9 edn (2016).
Ambrose A. R., Hazime K. S., Worboys J. D., Niembro-Vivanco O., & Davis D. M. Synaptic secretion from human natural killer cells is diverse and includes supramolecular attack particles. Proc. Natl Acad. Sci. USA 117, 23717–23720. (2020).
Chitirala, P. et al. Studying the biology of cytotoxic T lymphocytes in vivo with a fluorescent granzyme B-mTFP knock-in mouse. Elife 9, e58065 (2020).
pubmed: 32696761 pmcid: 7375811 doi: 10.7554/eLife.58065
Tam, Y. K. et al. Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy. Hum. Gene Ther. 10, 1359–1373 (1999).
pubmed: 10365666 doi: 10.1089/10430349950018030
Chitirala, P. et al. Role of V-ATPase a3-Subunit in Mouse CTL Function. J. Immunol. 204, 2818–2828 (2020).
pubmed: 32269094 doi: 10.4049/jimmunol.1901536
Suck, G. et al. NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy. Cancer Immunol. Immun. 65, 485–492 (2016).
doi: 10.1007/s00262-015-1761-x
Schmidt, H. et al. Effector granules in human T lymphocytes: proteomic evidence for two distinct species of cytotoxic effector vesicles. J. Proteome Res. 10, 1603–1620 (2011).
pubmed: 21247065 doi: 10.1021/pr100967v
Fu, W. et al. CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity. Nat. Commun. 10, 4355 (2019).
pubmed: 31554797 pmcid: 6761190 doi: 10.1038/s41467-019-12321-3
Lugini, L. et al. Immune surveillance properties of human NK cell-derived exosomes. J. Immunol. 189, 2833–2842 (2012).
pubmed: 22904309 doi: 10.4049/jimmunol.1101988
Zhu, L. et al. Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma. Theranostics 7, 2732–2745 (2017).
pubmed: 28819459 pmcid: 5558565 doi: 10.7150/thno.18752
Zhu, L. et al. Targeting and therapy of glioblastoma in a mouse model using exosomes derived from natural killer cells. Front Immunol. 9, 824 (2018).
pubmed: 29740437 pmcid: 5924812 doi: 10.3389/fimmu.2018.00824
Jong, A. Y. et al. Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells. J. Extracell. Vesicles 6, 1294368 (2017).
pubmed: 28326171 pmcid: 5345580 doi: 10.1080/20013078.2017.1294368
Dovrat, S. et al. 14-3-3 and beta-catenin are secreted on extracellular vesicles to activate the oncogenic Wnt pathway. Mol. Oncol. 8, 894–911 (2014).
pubmed: 24721736 pmcid: 5528515 doi: 10.1016/j.molonc.2014.03.011
Prakash, M. D. et al. Granzyme B promotes cytotoxic lymphocyte transmigration via basement membrane remodeling. Immunity 41, 960–972 (2014).
pubmed: 25526309 doi: 10.1016/j.immuni.2014.11.012
Isaaz, S., Baetz, K., Olsen, K., Podack, E. & Griffiths, G. M. Serial killing by cytotoxic T-lymphocytes-T-cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway. Eur. J. Immunol. 25, 1071–1079 (1995).
pubmed: 7737276 doi: 10.1002/eji.1830250432
Wiedemann, A., Depoil, D., Faroudi, M. & Valitutti, S. Cytotoxic T lymphocytes kill multiple targets simultaneously via spatiotemporal uncoupling of lytic and stimulatory synapses. Proc. Natl Acad. Sci. USA 103, 10985–10990 (2006).
pubmed: 16832064 pmcid: 1544161 doi: 10.1073/pnas.0600651103
Vasconcelos, Z. et al. Individual human cytotoxic T lymphocytes exhibit intraclonal heterogeneity during sustained killing. Cell Rep. 11, 1474–1485 (2015).
pubmed: 26027932 doi: 10.1016/j.celrep.2015.05.002
Stinchcombe, J. C., Page, L. J. & Griffiths, G. M. Secretory lysosome biogenesis in cytotoxic T lymphocytes from normal and Chediak Higashi syndrome patients. Traffic 1, 435–444 (2000).
pubmed: 11208129 doi: 10.1034/j.1600-0854.2000.010508.x
Ward, D. M., Griffiths, G. M., Stinchcombe, J. C. & Kaplan, J. Analysis of the lysosomal storage disease Chediak-Higashi syndrome. Traffic 1, 816–822 (2000).
pubmed: 11208072 doi: 10.1034/j.1600-0854.2000.011102.x
Huizing, M., Anikster, Y. & Gahl, W. A. Hermansky-Pudlak syndrome and related disorders of organelle formation. Traffic 1, 823–835 (2000).
pubmed: 11208073 doi: 10.1034/j.1600-0854.2000.011103.x
Dustin, M. L. & Colman, D. R. Neural and immunological synaptic relations. Science 298, 785–789 (2002).
pubmed: 12399580 doi: 10.1126/science.1076386
Becherer, U. et al. Regulated exocytosis in chromaffin cells and cytotoxic T lymphocytes: How similar are they? Cell Calcium 52, 303–312 (2012).
pubmed: 22560267 doi: 10.1016/j.ceca.2012.04.002
Jahn, R. & Sudhof, T. C. Membrane fusion and exocytosis. Annu. Rev. Biochem. 68, 863–911 (1999).
pubmed: 10872468 doi: 10.1146/annurev.biochem.68.1.863
Rettig, J. & Neher, E. Emerging roles of presynaptic proteins in Ca
pubmed: 12399579 doi: 10.1126/science.1075375
Dudenhöffer-Pfeifer, M. et al. Different Munc13 isoforms function as priming factors in lytic granule release from murine cytotoxic T lymphocytes. Traffic 14, 798–809 (2013).
pubmed: 23590328 doi: 10.1111/tra.12074
Dustin M. L., Starr T., Varma R. & Thomas V. K. Supported planar bilayers for study of the immunological synapse. Curr. Protoc. Immunol. Chapter 18, Unit 18.13 (2007).
Valvo, S. et al. Comprehensive analysis of immunological synapse phenotypes using supported lipid bilayers. Methods Mol. Biol. 1584, 423–441 (2017).
pubmed: 28255717 doi: 10.1007/978-1-4939-6881-7_26
Boyken, J. et al. Molecular profiling of synaptic vesicle docking sites reveals novel proteins but few differences between glutamatergic and GABAergic synapses. Neuron 78, 285–297 (2013).
pubmed: 23622064 doi: 10.1016/j.neuron.2013.02.027
Gilles, J. F., Dos Santos, M., Boudier, T. & Bolte, S. Heck N. DiAna, an ImageJ tool for object-based 3D co-localization and distance analysis. Methods 115, 55–64 (2017).
pubmed: 27890650 doi: 10.1016/j.ymeth.2016.11.016
Thery C., Amigorena S., Raposo G., Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol Chapter 3, Unit 3 22 (2006).
Liu, Y. et al. Two distinct secretory vesicle-priming steps in adrenal chromaffin cells. J. Cell Biol. 190, 1067–1077 (2010).
pubmed: 20855507 pmcid: 3101601 doi: 10.1083/jcb.201001164
Katsen-Globa, A., Puetz, N., Gepp, M. M., Neubauer, J. C. & Zimmermann, H. Study of SEM preparation artefacts with correlative microscopy: Cell shrinkage of adherent cells by HMDS-drying. Scanning 38, 625–633 (2016).
pubmed: 26878999 doi: 10.1002/sca.21310
Kremer, J. R., Mastronarde, D. N. & McIntosh, J. R. Computer visualization of three-dimensional image data using IMOD. J. Struct. Biol. 116, 71–76 (1996).
pubmed: 8742726 doi: 10.1006/jsbi.1996.0013
Shevchenko, A., Tomas, H., Havlis, J., Olsen, J. V. & Mann, M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 1, 2856–2860 (2006).
pubmed: 17406544 doi: 10.1038/nprot.2006.468
Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008).
pubmed: 19029910 doi: 10.1038/nbt.1511
Tyanova, S., Temu, T. & Cox, J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc. 11, 2301–2319 (2016).
pubmed: 27809316 doi: 10.1038/nprot.2016.136
Cox, J. et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794–1805 (2011).
pubmed: 21254760 doi: 10.1021/pr101065j
Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell Proteom. 13, 2513–2526 (2014).
doi: 10.1074/mcp.M113.031591
Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731–740 (2016).
pubmed: 27348712 doi: 10.1038/nmeth.3901
Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA 98, 5116–5121 (2001).
pubmed: 11309499 pmcid: 33173 doi: 10.1073/pnas.091062498
UniProt, C. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 47, D506–D515 (2019).
doi: 10.1093/nar/gky1049
Hulsen, T., de Vlieg, J. & Alkema, W. BioVenn - a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics 9, 488 (2008).
pubmed: 18925949 pmcid: 2584113 doi: 10.1186/1471-2164-9-488
Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 47, D442–D450 (2019).
pubmed: 30395289 doi: 10.1093/nar/gky1106

Auteurs

Hsin-Fang Chang (HF)

Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, 66421, Homburg, Germany. Hsin-Fang.Chang@uks.eu.

Claudia Schirra (C)

Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, 66421, Homburg, Germany.

Momchil Ninov (M)

Bioanalytical Mass Spectrometry, Max Planck Institute for Multidisciplinary Sciences, Am Fassberg 11, 37077, Göttingen, Germany.
Laboratory of Neurobiology, Max Planck Institute for Multidisciplinary Sciences, Am Fassberg 11, 37077, Göttingen, Germany.
Bioanalytics, Institute for Clinical Chemistry, University Medical Center Göttingen, Robert Koch Str. 40, 37075, Göttingen, Germany.

Ulrike Hahn (U)

Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, 66421, Homburg, Germany.

Keerthana Ravichandran (K)

Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, 66421, Homburg, Germany.

Elmar Krause (E)

Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, 66421, Homburg, Germany.

Ute Becherer (U)

Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, 66421, Homburg, Germany.

Štefan Bálint (Š)

Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, OX3 7FY, Oxford, UK.

Maria Harkiolaki (M)

Diamond Light Source, Harwell Science and Innovation Campus, OX11 0DE, Didcot, UK.

Henning Urlaub (H)

Bioanalytical Mass Spectrometry, Max Planck Institute for Multidisciplinary Sciences, Am Fassberg 11, 37077, Göttingen, Germany.
Bioanalytics, Institute for Clinical Chemistry, University Medical Center Göttingen, Robert Koch Str. 40, 37075, Göttingen, Germany.

Salvatore Valitutti (S)

Cancer Research Center of Toulouse, INSERM U1037, 31037, Toulouse, France.
Department of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France.

Cosima T Baldari (CT)

Department of Life Sciences, University of Siena, 53100, Siena, Italy.

Michael L Dustin (ML)

Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, OX3 7FY, Oxford, UK.

Reinhard Jahn (R)

Laboratory of Neurobiology, Max Planck Institute for Multidisciplinary Sciences, Am Fassberg 11, 37077, Göttingen, Germany.

Jens Rettig (J)

Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, 66421, Homburg, Germany. jrettig@uks.eu.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH